NEW YORK, August 31, 2026, 19:50 EDT —
- Ambev ADRs closed at $2.87, up 0.35%, then held unchanged after hours.
- Turnover reached 48.5 million shares, 71.8% above the three-month daily average.
- Brazil Beer’s second-quarter revenue rose 8.9% as normalized EBITDA gained 12.8%.
Ambev S.A. NYSE:ABEV edged up 0.35% on Monday. Its U.S. shares drew 48.5 million in volume, despite a one-cent gain. The ADR held at $2.87 at 19:30 EDT.
The mismatch matters. Turnover ran 71.8% above Ambev’s three-month average. Yet the narrow price response suggests portfolio flow, not a new earnings verdict.
ABEV intraday price
NYSE dollars per ADR; regular session
As of . Source: Yahoo Finance.
Ambev opened at $2.90 and touched $2.91. It then closed near the lower half of its $2.855-to-$2.91 range. A late burst supplied much of the day’s activity.
The 48.5 million shares also exceeded the 10-day average by 36.8%. Price remained 4.9% below its 50-day average. It sat 1.2% below the 200-day measure.
Turnover versus recent norms
Millions of ABEV ADRs
Regular session through 16:00 EDT on August 31, 2026. Source: Yahoo Finance.
No fresh company filing accompanied the volume. The SEC’s Ambev record listed August 14 as its latest 6-K. That document updated disclosure and securities-trading policies.
The fundamental case still rests on July’s results. Second-quarter organic revenue rose 6.1%. Organic normalized EBITDA grew 8.9%, while normalized profit increased 23.3%.
Brazil Beer’s operating ladder
Organic second-quarter change from a year earlier
Revenue and EBITDA outpaced volume, showing positive operating leverage.
Reported July 30, 2026. Source: Ambev 2Q26 results.
Brazil Beer supplied the clearest operating leverage. Volume rose 5.0%, helped by premium brands and World Cup demand. Revenue increased 8.9%, while normalized EBITDA advanced 12.8%.
Chief Executive Carlos Lisboa called it “another quarter of beer volume growth, with solid top and bottom-line performance.” The company estimated market-share gains across its Brazil portfolio. It also reported mid-twenties premium-volume growth.
Monday’s relative move favored Ambev. Anheuser-Busch InBev SA/NV NYSE:BUD lost 1.29%. Fomento Económico Mexicano NYSE:FMX added 0.24%.
Relevant U.S.-listed beverage shares
Regular-session change on August 31, 2026
Closes through 16:00 EDT. Sources: ABEV, FMX, and BUD on Yahoo Finance.
Ambev traded at 14.35 times trailing earnings. Its $44.3 billion market value leaves execution, rather than balance-sheet repair, as the near-term test. Operating cash flow rose 54.5% to R$4.71 billion last quarter.
Cash returns offer the next confirmed milestones. Ambev scheduled a R$1.9 billion interest-on-capital tranche for October 6. A further R$1.1 billion distribution is due by December.
Risks. Brazil Beer cash cost per hectoliter is still guided 4.5% to 7.5% higher this year. Currency and commodity pressure could erase the margin leverage. Canada and parts of Latin America also posted weaker volumes.
For now, the tape shows attention without conviction. Sustained upside needs Brazil Beer’s earnings growth to outlast the one-day volume surge.

